USA | Medical Systems USA | Medical SystemsWashington, DC, October 22, 2007 - ProSolv® CardioVascular, a FUJIFILM company, (ProSolv) will be demonstrating its advanced quantification capabilities this week at the TCT (Transcatheter Cardiovascular Therapeutics) 2007 Conference. These capabilities are a result of ProSolv's corporate partnership with Pie Medical Imaging BV (PMI, Maastricht, the Netherlands), a leading developer of quantitative analysis software for cardiology and radiology. The integration and distribution of PMI's CAAS software with ProSolv's industry-leading cardiovascular image and information system (CVIIS) provides efficiencies in quantification and reporting for the Cardiac Catheterization lab.
Pie Medical's CAAS 5 software can be launched directly from the ProSolv application. This enables QCA and LVA assessment including quantitative measurements of the dimensions of coronary arteries and analysis of the left ventricle immediately and without the added step of accessing a separate program. Furthermore, ProSolv has closed the loop by exporting the findings of the analysis - the analyzed images, reports, discrete data, and any other pertinent details - directly into the ProSolv database and clinical report.
ProSolv President and CEO, Aaron Waitz said, "Providing healthcare facilities with improved workflow, consistency, and accuracy in reporting from the both the clinical and administrative sides are paramount to us and our ongoing product development. This partnership with Pie Medical Imaging exemplifies our continued focus on the Cardiac Catheterization lab. The integration of PMI's CAAS application within the ProSolv application enables us to address their unique workflow needs, allowing us to continue to deliver solutions that bring additional value to our customers," said Waitz.
"The ProSolv - PMI alliance presents a unique opportunity for the two companies to create a comprehensive, state-of-the-art solution for healthcare facilities and physician practices," stated PMI's CEO Boudewijn Verstraelen. "We look forward to continuing a productive relationship with ProSolv."
For more information or for a product demonstration, visit ProSolv booth #3089 or PMI booth #1026 during TCT 2007 in Washington, DC.
About ProSolv® CardioVascular, a FUJIFILM Company
Founded in 1989 as Problem Solving Concepts, Inc. ("ProSolv®") and acquired by FUJIFILM Medical Systems in January 2007, ProSolv CardioVascular is a leading provider of enterprise-level information management solutions for the clinical analysis and management of digital medical images for cardiology. ProSolv's cardiovascular image and information system (CVIIS) is a vendor- and hardware-neutral, software only solution that supports any cardiovascular modality, including echocardiography, vascular ultrasound, cardiac catheterization, nuclear cardiology, ECG, and cardiac CT and MR. Superior reporting capabilities are among the many advantages of the ProSolv CVIIS. The company is headquartered in Indianapolis, Indiana. For more information visit www.prosolv.com.
About Pie Medical Imaging
Part of Esaote S.p.A. (Genoa, Italy), is a world market leader in quantitative analysis software for cardiology and radiology and well known for its CAAS products (such as CAAS QCA, LV, 3D and CAAS MR). Pie Medical Imaging designs and delivers software solutions that drive next-generation diagnostic and research worldwide from their offices in Maastricht, the Netherlands. Esaote S.p.A. is a leading manufacturer of medical Ultrasound equipment and the leader in dedicated MRI. More information is available at: www.piemedicalimaging.com or www.esaote.com.